Fig. 6From: DMAG, a novel countermeasure for the treatment of thrombocytopeniaMolecular docking and molecular dynamics simulation show the binding ability between DMAG and its core targets. a Detailed interactions of receptors (ITGA2B, ITGB3, TLR2, PLEK) and ligands (DMAG) by molecular docking. The yellow dotted line indicates the interaction between ligand and receptors. b The RMSD curves of receptors (ITGA2B, ITGB3, TLR2, PLEK) binding to ligands (DMAG) during 25Â ns by molecular dynamics simulationBack to article page